Cite
HARVARD Citation
Alavi, A. et al. (2022). Janus kinase 1 inhibitor INCB054707 for patients with moderate‐to‐severe hidradenitis suppurativa: results from two phase II studies. British journal of dermatology. pp. 803-813. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Alavi, A. et al. (2022). Janus kinase 1 inhibitor INCB054707 for patients with moderate‐to‐severe hidradenitis suppurativa: results from two phase II studies. British journal of dermatology. pp. 803-813. [Online].